Fibroblast growth factor receptor-2 expression in thyroid tumor progression: Potential diagnostic Application

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Redler, Adriano ^a   Di Rocco, Giorgio ^a   Giannotti, Domenico ^a   Frezzotti, Francesca ^a   Bernieri, Maria Giulia ^a   Ceccarelli, Simona ^a   D'Amici, Sirio ^a   Vescarelli, Enrica ^a   Paola Mitterhofer, Anna ^a   Angeloni, Antonio ^b   Marchese, Cinzia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2 IIIB; FIBROBLAST GROWTH FACTOR RECEPTOR 2 IIIC; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; FGFR2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID HYPERPLASIA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR DIAGNOSIS; TUMOR GROWTH; ADENOMA; CARCINOMA, PAPILLARY; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID NEOPLASMS;

ADENOMA; ADULT; AGED; CARCINOGENESIS; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84905403508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072224     Document Type: Article

References (29)

1. Brierley JD, Asa SL (2001) Thyroid cancer. In: Gospodarowicz MK, editor. Prognostic factors in cancer. New York: Wiley-Liss, Inc. 195-208
2. Asa SL, Bedard YC (2000) Fine-needle aspiration cytology and histopathology. In: Clark OH, Noguchi S, editors. Thyroid cancer. St. Louis, MO: Diagnosis and Treatment Quality Medical Publishing, Inc. 39-104
3. Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicularcell neoplasia. Nat Rev Cancer 6: 292-306
4. Marchese C, Chedid M, Dirsch OR, Csaky KG, Santanelli F, et al. (1995) Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 182: 1369-1376
5. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth factor Rev 16: 139-149
6. Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanada AM, et al. (1994) Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol 18: 207-216
7. Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, et al. (1998) The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89: 28-34
8. Giri D, Ropiquet F, Ittmann M (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5: 1063-1071
9. Ahmed NU, Ueda M, Ito A, Ohashi A, Funasaka Y, et al. (1997) Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma. Melanoma Res 7: 299-305
10. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, et al. (1996) Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours. J Pathol 178: 429-436
11. Shingu K, Fujimori M, Ito K, Hama Y, Kasuga Y, et al. (1998) Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions. Endocr J 45: 35-43
12. Eggo MC, Quiney VM, Campbell S (2003) Local factors regulating growth and function of human thyroid cells in vitro and in vivo. Mol Cell Endocrinol 213: 47-58
13. Thompson SD, Franklyn JA, Watkinson JC, Verhaeg JM, Sheppard C (1998) Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia. J Clin Endocrinol Metab 83: 1336-1341
14. Onose H, Emoto N, Sugihara H, Shimizu K, Wakabayashi I (1999) Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures. Eur J Endocrinol 140: 169-173
15. St Bernard R, Zheng L, Liu W, Winer D, Asa SL, et al. (2005) Fibroblast Growth Factor Receptors as Molecular Targets in Thyroid Carcinoma. Endocrinology 146: 1145-1153
16. Ezzat S, Huang P, Dackiw A, Asa SL (2005) Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res 11: 1336-1341
17. Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP (1994) Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 5: 851-862
18. Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, et al. (2006) Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci U S A 103: 14116-14121
19. Matsubara A, Kan M, Feng S, McKeehan WL (1998) Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 58: 1509-1514
20. Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, et al. (1999) Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene 18: 7234-7243
21. Yasumoto H, Matsubara A, Mutaguchi K, Usui T, McKeehan WL (2004) Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells. Prostate 61: 236-242
22. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, et al. (2000) FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 277: 643-649
23. Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23: 291-299
24. Hughes SE (1997) Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45: 1005-1019
25. Grose R, Dickson C (2005) Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 16: 179-186
26. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, et al. (2001) Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231: 47-62
27. Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, et al. (2009) Lossof-function fibroblast growth factor receptor-2 mutations in melanoma. Mol Cancer Res 7: 41-54
28. Kondo T, Zheng L, Liu W, Kurebayashi J, Asa SL, et al. (2007) Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/ BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res 67: 5461-5470
29. Kondo T, Zhu X, Asa SL, Ezzat S (2007) The Cancer/Testis AntigenMelanoma-Associated Antigen-A3/A6 Is a NovelTarget of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer. Clin Cancer Res 13: 4713-4720